Tuberous Sclerosis Global Clinical Trials Review, H2, 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 74
Inquire Before Buying

GlobalData's clinical trial report, "Tuberous Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Tuberous Sclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberous Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • The Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months


Reasons to buy


  • Assists in formulating key business strategies with regards to investment

  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost

  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Tuberous Sclerosis Global Clinical Trials Review, H2, 2016

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Tuberous Sclerosis Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Tuberous Sclerosis 28
Sep 06, 2016: Drug reduces seizure frequency in children with tuberous sclerosis complex 28
Clinical Trial Profile Snapshots 29
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74

List of Tables

Tuberous Sclerosis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Tuberous Sclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Tuberous Sclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Tuberous Sclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Tuberous Sclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Tuberous Sclerosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Tuberous Sclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 13
Tuberous Sclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Tuberous Sclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 16
Tuberous Sclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Tuberous Sclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Tuberous Sclerosis Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Tuberous Sclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Tuberous Sclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Tuberous Sclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Tuberous Sclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures

Tuberous Sclerosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Tuberous Sclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Tuberous Sclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Tuberous Sclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Tuberous Sclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Tuberous Sclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Tuberous Sclerosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 12
Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 13
Tuberous Sclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Tuberous Sclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Tuberous Sclerosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 16
Tuberous Sclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Tuberous Sclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Tuberous Sclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Tuberous Sclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Tuberous Sclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Tuberous Sclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Tuberous Sclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Tuberous Sclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
GlobalData Methodology 72

  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Efficacy of Stand-alone Power Sources Drive The Global Distributed Energy Generation Market
    The global market for distributed energy generation is expected to magnify at a momentous CAGR of 11.4% between 2016 and 2020. The small-scale generation of electricity, oscillating from a few kilowatts to multitudes of megawatts, is denoted as distributed energy generation. In this process, power is usually produced using renewable resources or by generators during consumption. [...]
  • Global Organic Food Market Makes A Mark in Developed Economies
    Buyers throughout the world are becoming more and more health cognizant, which has occasioned in an alteration in their palates and inclinations. The global organic food market was worth US$88.1 billion in 2015 is anticipated to record a CAGR of over 16% between 2015 and 2020. Amongst the various different food products available, the fruits [...]
  • Chicken Pox Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 51
    GlobalData's clinical trial report, "Chicken Pox Global Clinical Trials Review, H2, 2016" provides an overview of Chicken Pox clinical trials scenario. This report provides top line data relating to the clinical trials on Chicken Pox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type......
  • Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 63
    GlobalData's clinical trial report, "Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2016" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), p......
  • Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 115
    GlobalData's clinical trial report, "Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2016" provides an overview of Herpes Zoster (Shingles) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial sta......
  • Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 118
    GlobalData's clinical trial report, "Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2016" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial ......
  • Syphilis Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 42
    GlobalData's clinical trial report, "Syphilis Global Clinical Trials Review, H2, 2016" provides an overview of Syphilis clinical trials scenario. This report provides top line data relating to the clinical trials on Syphilis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report ......
  • Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 74
    GlobalData's clinical trial report, "Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H2, 2016" provides an overview of Genital Warts (Condylomata Acuminata) clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Warts (Condylomata Acuminata). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, ......
  • Filariasis Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 55
    GlobalData's clinical trial report, "Filariasis Global Clinical Trials Review, H2, 2016" provides an overview of Filariasis clinical trials scenario. This report provides top line data relating to the clinical trials on Filariasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. R......
  • Genital Herpes Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 78
    GlobalData's clinical trial report, "Genital Herpes Global Clinical Trials Review, H2, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and spo......
  • Gonorrhea Global Clinical Trials Review, H2, 2016
    Published: 14-Dec-2016        Price: US 2500 Onwards        Pages: 55
    GlobalData's clinical trial report, "Gonorrhea Global Clinical Trials Review, H2, 2016" provides an overview of Gonorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Gonorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Repo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs